These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37090535)

  • 21. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.
    Shrestha S; Chatterjee S; Rao KD; Dowdy DW
    J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27009179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
    Portnoy A; Arcand JL; Clark RA; Weerasuriya CK; Mukandavire C; Bakker R; Patouillard E; Gebreselassie N; Zignol M; Jit M; White RG; Menzies NA
    PLoS Med; 2023 Jul; 20(7):e1004252. PubMed ID: 37432972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines.
    Foster M; Hill PC; Setiabudiawan TP; Koeken VACM; Alisjahbana B; van Crevel R
    Immunol Rev; 2021 May; 301(1):122-144. PubMed ID: 33709421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination Strategies Against Mycobacterium tuberculosis: BCG and Beyond.
    Ferluga J; Yasmin H; Bhakta S; Kishore U
    Adv Exp Med Biol; 2021; 1313():217-240. PubMed ID: 34661897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
    Houben RM; Dodd PJ
    PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis.
    Bénard É; Drolet M; Laprise JF; Gingras G; Jit M; Boily MC; Bloem P; Brisson M
    Lancet Public Health; 2023 Oct; 8(10):e788-e799. PubMed ID: 37777288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.
    Feng S; McLellan J; Pidduck N; Roberts N; Higgins JP; Choi Y; Izu A; Jit M; Madhi SA; Mulholland K; Pollard AJ; Procter S; Temple B; Voysey M
    Health Technol Assess; 2024 Jul; 28(34):1-109. PubMed ID: 39046101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines.
    Yadav J; Verma S; Chaudhary D; Jaiwal PK; Jaiwal R
    Curr Pharm Biotechnol; 2019; 20(6):446-458. PubMed ID: 31208308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells.
    Abebe F
    Clin Exp Immunol; 2021 Apr; 204(1):32-40. PubMed ID: 33315236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.
    Ignatowicz L; Mazurek J; Leepiyasakulchai C; Sköld M; Hinkula J; Källenius G; Pawlowski A
    PLoS One; 2012; 7(7):e41205. PubMed ID: 22848444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saponin TQL1055 adjuvant-containing vaccine confers protection upon
    Ahmed M; Farris E; Swanson RV; Das S; Yang Y; Martin T; Khader SA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2302070. PubMed ID: 38190806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential impact of vaccination on tuberculosis burden in India: A modelling analysis.
    Arinaminpathy N; Rade K; Kumar R; Joshi RP; Rao R
    Indian J Med Res; 2023; 157(2&3):119-126. PubMed ID: 37202930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
    Ong E; He Y; Yang Z
    Infect Genet Evol; 2020 Jun; 80():104186. PubMed ID: 31923726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice.
    Shaku MT; Um PK; Ocius KL; Apostolos AJ; Pires MM; Bishai WR; Kana BD
    Elife; 2024 Apr; 13():. PubMed ID: 38639995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.